Breaking News Instant updates and real-time market news.

SHSP

SharpSpring

$15.42 /

+1.07 (+7.46%)

 07:52
11/17/20
 11/17
07:52
 11/17/20
07:52

SharpSpring price target raised to $18 from $14 at Canaccord

Canaccord analyst David Hynes raised the firm's price target on SharpSpring to $18 from $14 and keeps a Buy rating on the shares. The analyst noted the company laid out a framework for how the business and financial model should evolve over time. It said net revenue retention should evolve over time, the firm's newer cohorts are already outperforming the old, unit economics should scale and be profitable, and potential revenue growth of 25-35% through 2025.

  • 17

    Nov

SHSP SharpSpring
$15.42 /

+1.07 (+7.46%)

08/14/20 Roth Capital
SharpSpring price target raised to $15 from $12 at Roth Capital
07/22/20 Roth Capital
SharpSpring price target lowered to $12 from $14 at Roth Capital
04/15/20 Craig-Hallum
SharpSpring assumed with a Buy at Craig-Hallum
03/13/20 Lake Street
SharpSpring price target lowered to $14 from $17 at Lake Street

TODAY'S FREE FLY STORIES

Conference/Events
Jefferies investment analysts to hold analyst/industry conference call » 16:25
02/25/21
02/25
16:25
02/25/21
16:25

Investment Analysts,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Quaker Houghton sees FY21 adjusted EBITDA up over 20% vs. $222M in FY20  16:24
02/25/21
02/25
16:24
02/25/21
16:24
KWR

Quaker Houghton

$296.40 /

+1.4 (+0.47%)

 
ShowHide Related Items >><<
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

16:22 Today
Quaker Houghton CEO Michael Barry to retire
11/05/20
Quaker Houghton expects FY20 adjusted EBITDA to exceed $215M
09/16/20
Quaker Houghton raises quarterly dividend 2.6% to 39.5c per share
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

12/21/20 Sidoti
Quaker Houghton reinstated with a Neutral at Sidoti
12/11/20 Deutsche Bank
Quaker Houghton initiated with a Buy at Deutsche Bank
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

16:23 Today
Quaker Houghton reports Q4 adjusted EPS $1.63, consensus $1.52
11/05/20
Quaker Houghton reports Q3 adj. EPS $1.56, consensus 94c
03/11/21
Specialty Chemicals Virtual Conference
02/26/21
Quaker Houghton - KWR
Downgrade
Verra Mobility downgraded to Equal Weight from Overweight at Morgan Stanley » 16:24
02/25/21
02/25
16:24
02/25/21
16:24
VRRM

Verra Mobility

$14.15 /

-0.75 (-5.03%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRRM Verra Mobility
$14.15 /

-0.75 (-5.03%)

01/22/21
Verra Mobility acquires Redflex Holdings for A$146.1M
10/06/20
Verra Mobility to deploy CrossingGuard with three New York counties
VRRM Verra Mobility
$14.15 /

-0.75 (-5.03%)

02/12/21 BTIG
Verra Mobility price target raised to $18 from $15 at BTIG
01/22/21 William Blair
Verra Mobility acquisition should drive 15% share upside, says William Blair
11/24/20 BTIG
Verra Mobility price target raised to $15 from $13 at BTIG
11/23/20 Deutsche Bank
Verra Mobility price target raised to $13 from $12 at Deutsche Bank
VRRM Verra Mobility
$14.15 /

-0.75 (-5.03%)

11/05/20
Verra Mobility reports Q3 EPS 4c, consensus (2c)
03/01/21
Verra Mobility - VRRM
VRRM Verra Mobility
$14.15 /

-0.75 (-5.03%)

12/08/20
Unusual call flow in option market yesterday
12/07/20
Call spread buyer in Verra Mobility adding to position
Hot Stocks
Clearwater Paper: Demand for tissue products to be 'volatile' due to Covid-19 » 16:24
02/25/21
02/25
16:24
02/25/21
16:24
CLW

Clearwater Paper

$41.77 /

-1.305 (-3.03%)

"For the first…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

02/17/21
Clearwater Paper suspends Arkansas operations due to severe weather
11/04/20
Clearwater Paper falls -10.8%
08/31/20
Orion Engineered CAO Andre Isfort to depart, Bob Hrivnak to succeed
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

01/21/21 BMO Capital
Clearwater Paper initiated with an Outperform at BMO Capital
05/07/20 RBC Capital
Clearwater Paper upgraded to Outperform from Sector Perform at RBC Capital
05/06/20 RBC Capital
Clearwater Paper upgraded to Outperform at RBC Capital on 'clear tailwinds'
05/06/20 RBC Capital
Clearwater Paper upgraded to Outperform from Sector Perform at RBC Capital
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

16:23 Today
Clearwater Paper reports Q4 adjusted EPS $1.45 consensus $1.53
12/21/20
Clearwater Paper raises Q4 adj. EBITDA view to $71M-$76M from $52M-$62M
11/03/20
Clearwater Paper sees Q4 adj. EBITDA $52M-$62M vs. $20.2M last year
11/03/20
Clearwater Paper sees tissue product demand softening in Q4
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

11/03/20
Fly Intel: After-Hours Movers
17:00 Today
Clearwater Paper - CLW
03/09/21
Clearwater Paper
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

11/03/20
ClearWater Paper options imply 11.8% move in share price post-earnings
Earnings
Dicerna reports FY20 EPS ($1.52), consensus ($1.05) » 16:23
02/25/21
02/25
16:23
02/25/21
16:23
DRNA

Dicerna

$28.14 /

+0.11 (+0.39%)

Reports FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRNA Dicerna
$28.14 /

+0.11 (+0.39%)

02/11/21
Dicerna initiates dosing in clinical trial of nedosiran for PH3
01/05/21
Dicerna announces first Novo Nordisk nominated candidate under agreement
01/04/21
Dicerna reports enrollment completion of PHYOX2 nedosiran trial
11/16/20
Dicerna gets $10M milestone from Lilly pact, Lilly initiates LY3561774 trial
DRNA Dicerna
$28.14 /

+0.11 (+0.39%)

01/11/21 B. Riley Securities
Dicerna price target raised to $37 from $30 at B. Riley Securities
08/07/20 H.C. Wainwright
Dicerna price target raised to $35 from $32 at H.C. Wainwright
07/01/20 Baird
Dicerna elevated to Fresh Pick at Baird
05/12/20 RBC Capital
Dicerna initiated with an Outperform at RBC Capital
DRNA Dicerna
$28.14 /

+0.11 (+0.39%)

11/05/20
Dicerna reports Q3 EPS (29c), consensus (20c)
03/01/21
41st Annual Healthcare Virtual Conference
16:30 Today
Dicerna - DRNA
Hot Stocks
Evolent Health's Evolent Care Partners network adds two physician groups » 16:23
02/25/21
02/25
16:23
02/25/21
16:23
EVH

Evolent Health

$19.71 /

-1.115 (-5.35%)

Evolent Health announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

01/13/21
Evolent Health: Bright HealthCare to acquire True Health New Mexico
12/22/20
Evolent Health enters into a cooperation agreement with Engaged Capital
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

01/19/21 Piper Sandler
Evolent Health price target raised to $25 from $15 at Piper Sandler
01/07/21 Canaccord
Evolent Health price target raised to $20 from $16 at Canaccord
01/06/21 BTIG
Evolent Health initiated with a Buy at BTIG
11/06/20 Piper Sandler
Evolent Health price target lowered to $15 from $16 at Piper Sandler
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

16:21 Today
Evolent Health sees Q1 revenue $205M-$215M, consensus $229.29M
16:20 Today
Evolent Health sees 2021 revenue $830M-$880M, consensus $940.38M
16:19 Today
Evolent Health reports Q4 adjusted EPS (1c), consensus (5c)
11/05/20
Evolent Health sees Q4 adjusted revenue $249.0M-$264.0M, consensus $266.64M
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

10/08/20
Rent-A-Center, Evolent pitched at long ideas by Engaged's Welling
08/28/20
Evolent Health has seen strategic interest over last two years, Deal.com says
03/01/21
41st Annual Healthcare Virtual Conference
17:00 Today
Evolent Health - EVH
03/05/21
Evolent Health
Earnings
Quaker Houghton reports Q4 adjusted EPS $1.63, consensus $1.52 » 16:23
02/25/21
02/25
16:23
02/25/21
16:23
KWR

Quaker Houghton

$296.40 /

+1.4 (+0.47%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

16:22 Today
Quaker Houghton CEO Michael Barry to retire
11/05/20
Quaker Houghton expects FY20 adjusted EBITDA to exceed $215M
09/16/20
Quaker Houghton raises quarterly dividend 2.6% to 39.5c per share
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

12/21/20 Sidoti
Quaker Houghton reinstated with a Neutral at Sidoti
12/11/20 Deutsche Bank
Quaker Houghton initiated with a Buy at Deutsche Bank
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

11/05/20
Quaker Houghton reports Q3 adj. EPS $1.56, consensus 94c
03/11/21
Specialty Chemicals Virtual Conference
02/26/21
Quaker Houghton - KWR
Earnings
Collegium Pharmaceutical reports Q4 EPS 20c, consensus 29c » 16:23
02/25/21
02/25
16:23
02/25/21
16:23
COLL

Collegium Pharmaceutical

$26.04 /

-0.16 (-0.61%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COLL Collegium Pharmaceutical
$26.04 /

-0.16 (-0.61%)

02/12/21
Collegium Pharmaceutical to replace Iridium in S&P 600 at open on 2/12
02/08/21
Collegium Pharmaceutical to replace Iridium in S&P 600 at open on 2/12
01/06/21
Collegium Pharmaceutical sees FY21 adjusted EBITDA $160M-$170M
12/09/20
Synlogic appoints Collegium Pharmaceutical chairman Michael Heffernan to board
COLL Collegium Pharmaceutical
$26.04 /

-0.16 (-0.61%)

01/11/21 H.C. Wainwright
Collegium Pharmaceutical price target raised to $33 from $29 at H.C. Wainwright
12/29/20 Needham
Needham names Collegium Pharma Top Pick for 2021, adds to Conviction List
07/14/20 BWS Financial
Collegium Pharmaceutical initiated with a Sell at BWS Financial
05/27/20 Guggenheim
Guggenheim starts coverage of four pain treatment makers with two Buys
COLL Collegium Pharmaceutical
$26.04 /

-0.16 (-0.61%)

11/05/20
Collegium Pharmaceutical reports Q3 EPS 32c, consensus 22c
16:30 Today
Collegium Pharmaceutical - COLL
03/05/21
Collegium Pharmaceutical
Earnings
Clearwater Paper reports Q4 adjusted EPS $1.45 consensus $1.53 » 16:23
02/25/21
02/25
16:23
02/25/21
16:23
CLW

Clearwater Paper

$41.77 /

-1.305 (-3.03%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

02/17/21
Clearwater Paper suspends Arkansas operations due to severe weather
11/04/20
Clearwater Paper falls -10.8%
08/31/20
Orion Engineered CAO Andre Isfort to depart, Bob Hrivnak to succeed
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

01/21/21 BMO Capital
Clearwater Paper initiated with an Outperform at BMO Capital
05/07/20 RBC Capital
Clearwater Paper upgraded to Outperform from Sector Perform at RBC Capital
05/06/20 RBC Capital
Clearwater Paper upgraded to Outperform at RBC Capital on 'clear tailwinds'
05/06/20 RBC Capital
Clearwater Paper upgraded to Outperform from Sector Perform at RBC Capital
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

12/21/20
Clearwater Paper raises Q4 adj. EBITDA view to $71M-$76M from $52M-$62M
11/03/20
Clearwater Paper sees Q4 adj. EBITDA $52M-$62M vs. $20.2M last year
11/03/20
Clearwater Paper sees tissue product demand softening in Q4
11/03/20
Clearwater Paper reports Q3 EPS $1.28, consensus $1.38
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

11/03/20
Fly Intel: After-Hours Movers
17:00 Today
Clearwater Paper - CLW
03/09/21
Clearwater Paper
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

11/03/20
ClearWater Paper options imply 11.8% move in share price post-earnings
Conference/Events
UBS restaurants analyst to hold analyst/industry conference call » 16:22
02/25/21
02/25
16:22
02/25/21
16:22

Restaurants Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial
Hot Stocks
Quaker Houghton CEO Michael Barry to retire » 16:22
02/25/21
02/25
16:22
02/25/21
16:22
KWR

Quaker Houghton

$296.40 /

+1.4 (+0.47%)

Quaker Houghton announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

11/05/20
Quaker Houghton expects FY20 adjusted EBITDA to exceed $215M
09/16/20
Quaker Houghton raises quarterly dividend 2.6% to 39.5c per share
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

12/21/20 Sidoti
Quaker Houghton reinstated with a Neutral at Sidoti
12/11/20 Deutsche Bank
Quaker Houghton initiated with a Buy at Deutsche Bank
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

11/05/20
Quaker Houghton reports Q3 adj. EPS $1.56, consensus 94c
03/11/21
Specialty Chemicals Virtual Conference
02/26/21
Quaker Houghton - KWR
Earnings
Floor & Decor reports Q4 EPS 54c, consensus 44c » 16:22
02/25/21
02/25
16:22
02/25/21
16:22
FND

Floor & Decor

$93.93 /

-3.605 (-3.70%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FND Floor & Decor
$93.93 /

-3.605 (-3.70%)

10/29/20
Floor & Decor not guiding FY20
FND Floor & Decor
$93.93 /

-3.605 (-3.70%)

02/19/21
Fly Intel: Top five analyst upgrades
02/19/21 Piper Sandler
Floor & Decor upgraded to Overweight from Neutral at Piper Sandler
02/09/21 Wells Fargo
Floor & Decor price target raised to $120 from $105 at Wells Fargo
01/28/21 Telsey Advisory
Floor & Decor upgraded to Outperform from Market Perform at Telsey Advisory
FND Floor & Decor
$93.93 /

-3.605 (-3.70%)

10/29/20
Floor & Decor reports Q3 EPS 65c, consensus 40c
  • 11
    Aug
  • 20
    May
FND Floor & Decor
$93.93 /

-3.605 (-3.70%)

12/10/20
Goldman Sachs says buy Floor & Decor, sell Best Buy
10/29/20
Fly Intel: After-Hours Movers
03/11/21
2021 Consumer, Industrials, & TMT Investor Virtual Conference
17:00 Today
Floor & Decor - FND
03/05/21
Floor & Decor
Hot Stocks
Eventbrite sees modest pace of recovery in paid ticket volume, revenue in 1H » 16:21
02/25/21
02/25
16:21
02/25/21
16:21
EB

Eventbrite

$19.04 /

-1.82 (-8.72%)

The company said:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

09/16/20
Eventbrite says paid tickets grew 17% in August vs July
09/01/20
Zoom Video reports resignation of Chief Accounting Officer
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

12/16/20 JPMorgan
Eventbrite price target raised to $15 from $10 at JPMorgan
05/18/20
Fly Intel: Top five analyst upgrades
05/18/20 SunTrust
Eventbrite upgraded to Buy at SunTrust on valuation
05/18/20 SunTrust
Eventbrite upgraded to Buy from Hold at SunTrust
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

16:21 Today
Eventbrite reports Q4 EPS (22c) consensus (37c)
11/05/20
Eventbrite reports Q3 EPS (21c), consensus (41c)
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

11/09/20
Fly Intel: Wall Street's top stories for Monday
11/09/20
Fly Intel: Wall Street's top stories at midday
17:00 Today
Eventbrite - EB
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

09/03/20
Unusually active option classes on open September 3rd
Earnings
Eargo sees FY21 revenue $87M-$93M, consensus $87.73M » 16:21
02/25/21
02/25
16:21
02/25/21
16:21
EAR

Eargo

$61.13 /

-3.855 (-5.93%)

Sees FY21 fross margin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EAR Eargo
$61.13 /

-3.855 (-5.93%)

01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
11/10/20 JPMorgan
Eargo initiated with an Overweight at JPMorgan
11/10/20 William Blair
Eargo initiated with an Outperform at William Blair
EAR Eargo
$61.13 /

-3.855 (-5.93%)

16:19 Today
Eargo reports Q4 EPS (30c), consensus (21c)
01/11/21
Eargo sees FY20 revenue approximately $69M, consensus $64.63M
01/11/21
Eargo sees Q4 revenue $22.2M, consensus $17.78M
11/19/20
Eargo reports Q3 revenue $18.2M, consensus $18.14M
  • 16
    Oct
EAR Eargo
$61.13 /

-3.855 (-5.93%)

11/19/20
Fly Intel: After-Hours Movers
10/18/20
Opening Day: Array jumps after $1.05B IPO
16:30 Today
Eargo - EAR
EAR Eargo
$61.13 /

-3.855 (-5.93%)

01/20/21
Five new option listings on January 20th
Earnings
Evolent Health sees Q1 revenue $205M-$215M, consensus $229.29M » 16:21
02/25/21
02/25
16:21
02/25/21
16:21
EVH

Evolent Health

$19.71 /

-1.115 (-5.35%)

Adjusted EBITDA is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

01/13/21
Evolent Health: Bright HealthCare to acquire True Health New Mexico
12/22/20
Evolent Health enters into a cooperation agreement with Engaged Capital
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

01/19/21 Piper Sandler
Evolent Health price target raised to $25 from $15 at Piper Sandler
01/07/21 Canaccord
Evolent Health price target raised to $20 from $16 at Canaccord
01/06/21 BTIG
Evolent Health initiated with a Buy at BTIG
11/06/20 Piper Sandler
Evolent Health price target lowered to $15 from $16 at Piper Sandler
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

16:20 Today
Evolent Health sees 2021 revenue $830M-$880M, consensus $940.38M
16:19 Today
Evolent Health reports Q4 adjusted EPS (1c), consensus (5c)
11/05/20
Evolent Health sees Q4 adjusted revenue $249.0M-$264.0M, consensus $266.64M
11/05/20
Evolent Health backs 2020 adj. revenue view $1.0B-$1.01B, consensus $1.02B
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

10/08/20
Rent-A-Center, Evolent pitched at long ideas by Engaged's Welling
08/28/20
Evolent Health has seen strategic interest over last two years, Deal.com says
03/01/21
41st Annual Healthcare Virtual Conference
17:00 Today
Evolent Health - EVH
03/05/21
Evolent Health
Earnings
Eventbrite reports Q4 EPS (22c) consensus (37c) » 16:21
02/25/21
02/25
16:21
02/25/21
16:21
EB

Eventbrite

$19.04 /

-1.82 (-8.72%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

09/16/20
Eventbrite says paid tickets grew 17% in August vs July
09/01/20
Zoom Video reports resignation of Chief Accounting Officer
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

12/16/20 JPMorgan
Eventbrite price target raised to $15 from $10 at JPMorgan
05/18/20
Fly Intel: Top five analyst upgrades
05/18/20 SunTrust
Eventbrite upgraded to Buy at SunTrust on valuation
05/18/20 SunTrust
Eventbrite upgraded to Buy from Hold at SunTrust
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

11/05/20
Eventbrite reports Q3 EPS (21c), consensus (41c)
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

11/09/20
Fly Intel: Wall Street's top stories for Monday
11/09/20
Fly Intel: Wall Street's top stories at midday
17:00 Today
Eventbrite - EB
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

09/03/20
Unusually active option classes on open September 3rd
Earnings
BeiGene reports Q4 EPS ($5.20), consensus ($4.81) » 16:20
02/25/21
02/25
16:20
02/25/21
16:20
BGNE

BeiGene

$330.07 /

-7.12 (-2.11%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BGNE BeiGene
$330.07 /

-7.12 (-2.11%)

02/17/21
BeiGene, Boston Immune enter into pact to develop novel TNFR2 antagonists
02/17/21
BeiGene announces FDA acceptance of Brukinsa sNDA
01/27/21
BeiGene announces positive topline results in ph3 trial of Tislelizumab in ESCC
01/14/21
BeiGene announces tislelizumab combination receives China NMPA approval
BGNE BeiGene
$330.07 /

-7.12 (-2.11%)

02/18/21 Cowen
BeiGene price target raised to $429 from $348 at Cowen
01/12/21 Piper Sandler
BeiGene price target raised to $190 from $185 at Piper Sandler
12/29/20 Piper Sandler
BeiGene NRDL inclusions 'absolutely critical,' says Piper Sandler
12/08/20 Ladenburg
Ladenburg upgrades BeiGene to Buy after product approvals, ASH data
BGNE BeiGene
$330.07 /

-7.12 (-2.11%)

11/05/20
BeiGene reports Q3 loss per ADS ($4.81), consensus ($4.12)
  • 02
    Dec
03/01/21
41st Annual Healthcare Virtual Conference
10/18/21
PDUFA Date for Brukinsa Zanubrutinib (BGB-3111)
Earnings
Evolent Health sees 2021 revenue $830M-$880M, consensus $940.38M » 16:20
02/25/21
02/25
16:20
02/25/21
16:20
EVH

Evolent Health

$19.71 /

-1.115 (-5.35%)

Adjusted EBITDA is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

01/13/21
Evolent Health: Bright HealthCare to acquire True Health New Mexico
12/22/20
Evolent Health enters into a cooperation agreement with Engaged Capital
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

01/19/21 Piper Sandler
Evolent Health price target raised to $25 from $15 at Piper Sandler
01/07/21 Canaccord
Evolent Health price target raised to $20 from $16 at Canaccord
01/06/21 BTIG
Evolent Health initiated with a Buy at BTIG
11/06/20 Piper Sandler
Evolent Health price target lowered to $15 from $16 at Piper Sandler
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

16:19 Today
Evolent Health reports Q4 adjusted EPS (1c), consensus (5c)
11/05/20
Evolent Health sees Q4 adjusted revenue $249.0M-$264.0M, consensus $266.64M
11/05/20
Evolent Health backs 2020 adj. revenue view $1.0B-$1.01B, consensus $1.02B
11/05/20
Evolent Health reports Q3 adjusted EPS (3c), consensus (4c)
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

10/08/20
Rent-A-Center, Evolent pitched at long ideas by Engaged's Welling
08/28/20
Evolent Health has seen strategic interest over last two years, Deal.com says
03/01/21
41st Annual Healthcare Virtual Conference
17:00 Today
Evolent Health - EVH
03/05/21
Evolent Health
Earnings
BioMarin sees FY21 revenue $1.75B-$1.85B, consensus $1.91B » 16:20
02/25/21
02/25
16:20
02/25/21
16:20
BMRN

BioMarin

$81.86 /

-1.48 (-1.78%)

Sees FY21 GAAP net loss…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMRN BioMarin
$81.86 /

-1.48 (-1.78%)

01/10/21
BioMarin announces topline results from ongoing global Phase 3 GENEr8-1 study
12/21/20
BioMarin reports results of Phase 3 extension study of vosoritide
11/17/20
BioMarin and Deep Genomics enter into preclinical collaboration
11/09/20
BioMarin expands clinical program for vosoritide with new studies
BMRN BioMarin
$81.86 /

-1.48 (-1.78%)

01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
01/11/21 Baird
BioMarin price target raised to $110 from $100 at Baird
12/21/20 Piper Sandler
BioMarin data today should ease approvability concerns, says Piper Sandler
12/17/20 JPMorgan
BioMarin remains 'highest conviction name' at JPMorgan
BMRN BioMarin
$81.86 /

-1.48 (-1.78%)

16:17 Today
BioMarin reports Q4 EPS 12c, consensus (19c)
11/05/20
BioMarin sees FY20 revenue $1.81B-$1.87B, consensus $1.86B
11/05/20
BioMarin reports Q3 adjusted EPS $4.01, consensus $1.29
BMRN BioMarin
$81.86 /

-1.48 (-1.78%)

02/02/21
Amicus, BioMarin speculated by Dealreporter as possible Vertex targets
03/01/21
41st Annual Healthcare Virtual Conference
16:30 Today
BioMarin - BMRN
08/20/21
PDUFA Date for Vosoritide
BMRN BioMarin
$81.86 /

-1.48 (-1.78%)

09/18/20
BioMarin call volume above normal and directionally bullish
Earnings
Universal Health sees FY21 adjusted EPS $10.05-$11.05, consensus $10.75 » 16:20
02/25/21
02/25
16:20
02/25/21
16:20
UHS

Universal Health

$135.04 /

-2.825 (-2.05%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UHS Universal Health
$135.04 /

-2.825 (-2.05%)

09/29/20
Universal Health announces information technology security incident
09/08/20
Universal Health CEO Alan Miller to step down in 2021, Marc Miller to succeed
UHS Universal Health
$135.04 /

-2.825 (-2.05%)

01/05/21 Deutsche Bank
Universal Health price target raised to $145 from $135 at Deutsche Bank
01/05/21 BofA
BofA sees tailwinds for healthcare facilities, names HCA Healthcare top pick
01/05/21 BofA
Universal Health downgraded to Underperform from Neutral at BofA
12/18/20 Mizuho
Universal Health price target raised to $151 from $130 at Mizuho
UHS Universal Health
$135.04 /

-2.825 (-2.05%)

16:19 Today
Universal Health reports Q4 adjusted EPS $3.59, consensus $2.78
10/29/20
Universal Health reports Q3 adjusted EPS $2.88, consensus $1.92
10/29/20
Notable companies reporting after market close
UHS Universal Health
$135.04 /

-2.825 (-2.05%)

11/10/20
Supreme Court appears unlikely to topple ACA, USA Today says
09/28/20
Universal Health hospitals hit by Ryuk ransomware attack, TechCrunch reports
UHS Universal Health
$135.04 /

-2.825 (-2.05%)

11/14/20
Week in review: How Trump's policies moved stocks
10/29/20
Fly Intel: After-Hours Movers
02/26/21
Universal Health - UHS
Options
Closing CBOE SPX and VIX Index summary for February 25th » 16:20
02/25/21
02/25
16:20
02/25/21
16:20
VIX

Volatility Index S&P 500 Options

$0.00 /

+ (+0.00%)

The CBOE Volatility Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIX Volatility Index S&P 500 Options
$0.00 /

+ (+0.00%)

09:18 Today
Overnight activity included 1020 trades in SPX and 33 trades in VIX
02/24/21
Closing CBOE SPX and VIX Index summary for February 24th
02/24/21
Overnight activity included 2039 trades in SPX and 24 trades in VIX
02/23/21
Closing CBOE SPX and VIX Index summary for February 23rd
Earnings
Eargo reports Q4 EPS (30c), consensus (21c) » 16:19
02/25/21
02/25
16:19
02/25/21
16:19
EAR

Eargo

$61.13 /

-3.855 (-5.93%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EAR Eargo
$61.13 /

-3.855 (-5.93%)

01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
11/10/20 JPMorgan
Eargo initiated with an Overweight at JPMorgan
11/10/20 William Blair
Eargo initiated with an Outperform at William Blair
EAR Eargo
$61.13 /

-3.855 (-5.93%)

01/11/21
Eargo sees FY20 revenue approximately $69M, consensus $64.63M
01/11/21
Eargo sees Q4 revenue $22.2M, consensus $17.78M
11/19/20
Eargo reports Q3 revenue $18.2M, consensus $18.14M
  • 16
    Oct
EAR Eargo
$61.13 /

-3.855 (-5.93%)

11/19/20
Fly Intel: After-Hours Movers
10/18/20
Opening Day: Array jumps after $1.05B IPO
16:30 Today
Eargo - EAR
EAR Eargo
$61.13 /

-3.855 (-5.93%)

01/20/21
Five new option listings on January 20th
Hot Stocks
iHeartMedia announces new operating structure » 16:19
02/25/21
02/25
16:19
02/25/21
16:19
IHRT

iHeartMedia

$13.66 /

-0.82 (-5.66%)

The company says:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IHRT iHeartMedia
$13.66 /

-0.82 (-5.66%)

02/17/21
E.W. Scripps to sell Triton Digital to iHeartMedia for $230M
12/22/20
iHeartMedia names Jordan Fasbender EVP General Counsel and Secretary
11/25/20
iHeartMedia, Podimo announce strategic partnership
11/05/20
iHeartMedia receives FCC approval to increase foreign ownership to 100%
IHRT iHeartMedia
$13.66 /

-0.82 (-5.66%)

01/19/21 Wells Fargo
iHeartMedia price target raised to $20 from $14 at Wells Fargo
12/18/20 BofA
iHeartMedia cut to Underperform at BofA on low visibility in ad trends
12/18/20 BofA
iHeartMedia downgraded to Underperform from Neutral at BofA
07/24/20 B. Riley FBR
iHeartMedia price target raised to $11 from $8.50 at B. Riley FBR
IHRT iHeartMedia
$13.66 /

-0.82 (-5.66%)

11/09/20
iHeartMedia reports Q3 adjusted EBITDA $162M vs $275M last year
IHRT iHeartMedia
$13.66 /

-0.82 (-5.66%)

09/08/20
Former President Bill Clinton to launch podcast for iHeartMedia, Deadline says
IHRT iHeartMedia
$13.66 /

-0.82 (-5.66%)

12/18/20
Palantir downgrade at Credit Suisse among today's top calls on Wall Street
16:30 Today
iHeartMedia - IHRT
Earnings
Evolent Health reports Q4 adjusted EPS (1c), consensus (5c) » 16:19
02/25/21
02/25
16:19
02/25/21
16:19
EVH

Evolent Health

$19.71 /

-1.115 (-5.35%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

01/13/21
Evolent Health: Bright HealthCare to acquire True Health New Mexico
12/22/20
Evolent Health enters into a cooperation agreement with Engaged Capital
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

01/19/21 Piper Sandler
Evolent Health price target raised to $25 from $15 at Piper Sandler
01/07/21 Canaccord
Evolent Health price target raised to $20 from $16 at Canaccord
01/06/21 BTIG
Evolent Health initiated with a Buy at BTIG
11/06/20 Piper Sandler
Evolent Health price target lowered to $15 from $16 at Piper Sandler
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

11/05/20
Evolent Health sees Q4 adjusted revenue $249.0M-$264.0M, consensus $266.64M
11/05/20
Evolent Health backs 2020 adj. revenue view $1.0B-$1.01B, consensus $1.02B
11/05/20
Evolent Health reports Q3 adjusted EPS (3c), consensus (4c)
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

10/08/20
Rent-A-Center, Evolent pitched at long ideas by Engaged's Welling
08/28/20
Evolent Health has seen strategic interest over last two years, Deal.com says
03/01/21
41st Annual Healthcare Virtual Conference
17:00 Today
Evolent Health - EVH
03/05/21
Evolent Health
Earnings
Monster Beverage reports Q4 ex-items EPS 62c, consensus 62c » 16:19
02/25/21
02/25
16:19
02/25/21
16:19
MNST

Monster Beverage

$85.42 /

-2.87 (-3.25%)

Reports Q4 revenue $1.2B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNST Monster Beverage
$85.42 /

-2.87 (-3.25%)

01/14/21
Monster Beverage announces Hilton Schlosberg as co-CEO, Thomas Kelly as CFO
11/05/20
Monster Beverage not experiencing significant raw material shortages
11/05/20
Monster Beverage doesn't see COVID having material impact on liquidity
10/30/20
Monster Beverage appoints James Dinkins as director of the board
MNST Monster Beverage
$85.42 /

-2.87 (-3.25%)

01/19/21 Bernstein
Monster Beverage initiated with a Market Perform at Bernstein
01/15/21 Truist
Monster Beverage price target raised to $105 from $95 at Truist
01/15/21 Deutsche Bank
Monster Beverage price target raised to $102 from $99 at Deutsche Bank
01/15/21 Citi
Monster Beverage price target raised to $99 from $89 at Citi
MNST Monster Beverage
$85.42 /

-2.87 (-3.25%)

13:52 Today
Notable companies reporting after market close
11/05/20
Monster Beverage reports Q3 EPS 65c, consensus 63c
11/05/20
Notable companies reporting after market close
MNST Monster Beverage
$85.42 /

-2.87 (-3.25%)

12/08/20
Lowe's upgrade, Coca-Cola initiation among today's top calls on Wall Street
11/03/20
Pinduoduo, Monster Beverage upgrades among today's top calls on Wall Street
17:00 Today
Monster Beverage - MNST
MNST Monster Beverage
$85.42 /

-2.87 (-3.25%)

02/12/21
Bullish collar buyer thirsty for upside in Monster Beverage

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.